Hypertension Trial, Recruiting NCT07504055 Sponsor: University of Louisville Condition: Hypertension
Back to Hypertension

Hypertension Trial, Recruiting

NCT07504055
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are at least 18 years old
  • People whose overall health condition is stable
  • People who have a spinal cord injury (SCI) that has not gotten worse neurologically since at least 6 months after the injury, or in the 6 months before screening
  • People whose spinal cord injury is classified as motor-complete (meaning significant loss of movement), rated as grade "A," "B," or "C" on a standard spinal cord injury scale, with the injury located above a specific spinal level (T1) (confirm with trial site)
  • People whose spinal cord injury occurred at least 12 months before entering the study
  • People who have symptoms of low blood pressure when changing positions (such as dizziness or lightheadedness), confirmed by a symptom assessment score above zero
  • People whose kidneys are functioning normally, based on specific blood test results within defined ranges (confirm with trial site)
  • People who are able to give informed consent and follow instructions for the study

Who may not be able to join:

  • People with serious lung or heart disease that is not related to their spinal cord injury
  • People who depend on a ventilator to breathe
  • People with painful muscle or bone problems that could interfere with testing or the stimulation used in the trial
  • People with a bone fracture that has not fully healed and could interfere with testing or stimulation
  • People with a joint contracture (stiffness or tightening) that has not healed and could interfere with testing or stimulation
  • People with a pressure sore that has not healed and could interfere with testing or stimulation
  • People with depression or psychiatric conditions that are clinically significant and currently untreated
  • People who are currently misusing drugs or substances
  • People who have been diagnosed with cancer
  • People with a very high BMI (over 40) and at least one of the following: type 2 diabetes confirmed by two blood tests, or high blood pressure (consistently 140/90 mmHg or above, or currently taking blood pressure medication)
  • People with a blood clot in a deep vein (DVT), whether acute or ongoing
  • People whose low blood pressure is caused by a condition unrelated to their spinal cord injury, such as anaemia, fluid imbalance, or hormonal or neurological disorders
  • People with a significant problem affecting the oesophagus or digestive system
  • People who are currently pregnant (applies to females of childbearing potential)
  • People with any other major medical condition that the trial site determines would make testing or stimulation unsafe (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Alexander Ovechkin, University of Louisville

Phone: 1-502-581-8675

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of Louisville
Registry
ClinicalTrials.gov
Start date
1 April 2026
Est. completion
1 February 2029

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Baroreflex Sensitivity; Renal Artery Systolic Velocity (Right and Left); Plasma Renin Activity; Angiotensin Converting Enzyme; Aldosterone

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov